Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.920
+0.010 (0.34%)
At close: Jul 1, 2025, 4:00 PM
2.860
-0.060 (-2.05%)
After-hours: Jul 1, 2025, 7:55 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $2.14 million as of July 1, 2025. Its market cap has decreased by -48.81% in one year.
Market Cap
2.14M
Enterprise Value
-1.22M
1-Year Change
-48.81%
Ranking
Category
Stock Price
$2.92
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $2.14M, a decrease of -99.81%. That is a compound annual growth rate of -78.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 2.14M | -66.03% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |